Glucose monitoring: An important tool for improving glucose control and reducing hypoglycemia

Diabetes Technology and Therapeutics

Volumn 10, Issue SUPPL. 1, 2008, Pages

  Garg, Satish K ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 1 PHOSPHATE; HEMOGLOBIN A1C;

DIABETES MELLITUS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPOGLYCEMIA; INCIDENCE; INSULIN TREATMENT; PRIORITY JOURNAL; REVIEW; RISK; SELF MONITORING;

EID: 44249105977     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0008     Document Type: Review

References (32)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
3. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-2167.
4. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
5. Gilmer TP, O'Connor PJ, Manning WG, Rush WA: The cost to health plans of poor glycemic control. Diabetes Care 1997;20:1847-1853.
6. Schiffrin A, Belmonte M: Multiple daily self glucose monitoring: its essential role in long term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care 1982;5:479-484.
7. Brewer KW, Owen S, Garg SK, Chase HP: Slicing the pie: correlating hemoglobin A1c (HbA1c) values with average blood glucose (ABG) values in a pie chart form. Diabetes Care 1998;21:209-212.
8. Hönes J, Müller P, Surridge N: The technology behind glucose meters: test strips. Diabetes Technol Ther 2008;10(Suppl 1):S10-S26.
9. Subramanian SL, Hirsch IB: The utility and recent advances in self-monitoring of blood glucose in type 1 diabetes. Diabetes Technol Ther 2008;10(Suppl 1):S43-S50.
10. Poolsup N, Suksomboon N, Jiamsathit W: Systematic review of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients. Diabetes Technol Ther 2008;10(Suppl 1):S51-S66.
11. Naik RG, Ellis SL: Self-monitoring of blood glucose in insulin-requiring type 2 diabetes. Diabetes Technol Ther 2008;10(Suppl 1):S67-S71.
12. Joshi SR: Self-monitoring of blood glucose in the Asia-Pacific region. Diabetes Technol Ther 2008;10(Suppl 1):S89-S92.
13. Schnell O, Hummel M, Weber C: Economic and clinical aspects of diabetes regarding self-monitoring of blood glucose. Diabetes Technol Ther 2008;10(Suppl 1):S72-S81.
14. Nielsen JK, Christiansen JS: Self-monitoring of blood glucose - epidemiological and practical aspects. Diabetes Technol Ther 2008;10(Suppl 1):S35-S42.
15. Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB Jr, Ferrara A, Liu J, Selby JV: Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001;111:1-9.
16. Heinemann L, Koschinsky T: Clinical application and challenges of blood glucose measurement technology for self-monitoring. Diabetes Technol Ther 2008;10(Suppl 1):S27-S34.
17. Owens DR: History and vision: what is important for patients with diabetes? Diabetes Technol Ther 2008;10(Suppl 1):S5-S9.
18. Laird T, Zisser H, Jovanovic L: Self-monitoring of blood glucose in pregnancy: past to present. Diabetes Technol Ther 2008;10(Suppl 1):S82-S88.
19. Mazze R: The future of self-monitored blood glucose: mean blood glucose versus glycosylated hemoglobin. Diabetes Technol Ther 2008;10(Suppl 1):S93-S101.
20. Garg SK, Bookout TR, McFann KK, Kelly WC, Beatson C, Ellis SL, Gutin RS, Gottlieb PA: Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software [abstract]. Diabetes 2008;58(Suppl 1):A1212.
21. Chase HP, Kim LM, Owen SL, MacKenzie TA, Klingensmith GJ, Murtfeldt R, Garg SK: Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 2001;107:222-226.
22. Ludvigsson J, Hanas R: Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003;111:933-938.
23. Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, Tobian J, Gross T, Mastrototaro J: Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 2004;79:1521-1526.
24. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999;43:183-190.
25. Schaepelynck-Belicar P, Vague P, Simonin G, Lassmann-Vague V: Improved metabolic control in diabetic adolescents using the Continuous Glucose Monitoring System (CGMS). Diabetes Metab 2003;29:608-612.
26. Garg S, Jovanovic L: Relationship of fasting and hourly glucose values to A1C levels; safety, accuracy, and improvement in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006;29:2644-2649.
27. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29:44-50.
28. Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004;27:734-738.
29. Garg SK, Kelly WC, Voelmle MK, Ritchie PJ, Gottlieb PA, McFann KK, Ellis SL: Improved glycaemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care 2007;30:3023-3025.
30. Executive summary: standards of medical care in diabetes - 2008 in clinical practice recommendations 2008. Diabetes Care 2008;31(Suppl 1):S5-S6.
31. American Diabetes Association: Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008; 31:596-615.
32. Media Telephone Briefing: NHLBI changes intensive blood sugar treatment strategy in ACCORD clinical trial [unedited transcript]. Striar D, Nabel E, Friedewald W, Gerstein H, Fradkin J, Buse J, Byington R, Simons-Morton D, speakers. February 6, 2008. http://www.nhlbi.nih.gov/health/prof/heart/other/ accord/transcript.pdf.